| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 1869 | 2016 |
| Non-alcoholic fatty liver disease and diabetes JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson Metabolism 65 (8), 1096-1108, 2016 | 571 | 2016 |
| Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis MJ Armstrong, D Hull, K Guo, D Barton, JM Hazlehurst, LL Gathercole, ... Journal of hepatology 64 (2), 399-408, 2016 | 433 | 2016 |
| Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort MZ Cader, A Filer, J Hazlehurst, P De Pablo, CD Buckley, K Raza Annals of the rheumatic diseases 70 (6), 949-955, 2011 | 216 | 2011 |
| Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders JM Hazlehurst, JW Tomlinson European Journal of Endocrinology 169 (2), R27-R37, 2013 | 108 | 2013 |
| Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non‐alcoholic steatohepatitis MJ Armstrong, JM Hazlehurst, D Hull, K Guo, S Borrows, J Yu, SC Gough, ... Diabetes, Obesity and Metabolism 16 (7), 651-660, 2014 | 78 | 2014 |
| The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population S Mujahid, KF Hunt, YS Cheah, E Forsythe, JM Hazlehurst, K Sparks, ... The Journal of Clinical Endocrinology & Metabolism 103 (5), 1834-1841, 2018 | 73 | 2018 |
| Dual-5α-reductase inhibition promotes hepatic lipid accumulation in man JM Hazlehurst, AI Oprescu, N Nikolaou, R Di Guida, AEK Grinbergs, ... The Journal of Clinical Endocrinology & Metabolism 101 (1), 103-113, 2016 | 73 | 2016 |
| Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo JM Hazlehurst, LL Gathercole, M Nasiri, MJ Armstrong, S Borrows, J Yu, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1631-1640, 2013 | 73 | 2013 |
| Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management MJ Armstrong, JM Hazlehurst, R Parker, E Koushiappi, J Mann, S Khan, ... QJM: An International Journal of Medicine 107 (1), 33-41, 2014 | 61 | 2014 |
| Prevalence and severity of non‐alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching … T Marjot, E Sbardella, A Moolla, JM Hazlehurst, GD Tan, M Ainsworth, ... Diabetic Medicine 35 (1), 89-98, 2018 | 46 | 2018 |
| Developing integrated clinical pathways for the management of clinically severe adult obesity: a critique of NHS England policy JM Hazlehurst, J Logue, HM Parretti, S Abbott, A Brown, DJ Pournaras, ... Current obesity reports 9, 530-543, 2020 | 45 | 2020 |
| Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice MJ Armstrong, C Corbett, J Hodson, N Marwah, R Parker, DD Houlihan, ... Postgraduate medical journal 89 (1058), 685-692, 2013 | 44 | 2013 |
| A comparative quality assessment of evidence‐based clinical guidelines in endocrinology JM Hazlehurst, MJ Armstrong, M Sherlock, IA Rowe, MW O'Reilly, ... Clinical endocrinology 78 (2), 183-190, 2013 | 43 | 2013 |
| Advanced non‐alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome LL Gathercole, JM Hazlehurst, MJ Armstrong, R Crowley, S Boocock, ... Liver International 36 (11), 1704-1712, 2016 | 30 | 2016 |
| SFRP2 is associated with increased adiposity and VEGF expression RK Crowley, MW O’Reilly, IJ Bujalska, ZK Hassan-Smith, JM Hazlehurst, ... PLoS One 11 (9), e0163777, 2016 | 30 | 2016 |
| Prognostic models for predicting remission of diabetes following bariatric surgery: a systematic review and meta-analysis P Singh, NJ Adderley, J Hazlehurst, M Price, AA Tahrani, ... Diabetes care 44 (11), 2626-2641, 2021 | 25 | 2021 |
| Markers of adipose tissue hypoxia are elevated in subcutaneous adipose tissue of severely obese patients with obesity hypoventilation syndrome but not in the moderately obese M Todorčević, AR Manuel, L Austen, Z Michailidou, JM Hazlehurst, ... International Journal of Obesity 45 (7), 1618-1622, 2021 | 20 | 2021 |
| Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure TR Lim, JM Hazlehurst, AI Oprescu, MJ Armstrong, SF Abdullah, ... Clinical endocrinology 90 (3), 440-448, 2019 | 20 | 2019 |
| team Lt, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hubscher SG, Newsome PN. Liraglutide safety and efficacy in patients with non-alcoholic … MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... Lancet 387 (10019), 679-90, 2016 | 16 | 2016 |
